CRVS · Corvus Pharmaceuticals, Inc.
Market Cap
$1.19B
Shares
84.12M
Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
No Congressional Trades
No congressional trading data is available for this listed security yet.
Key facts
CIK
1626971
CUSIP
221015100
13F (30d)
139 filings
139 filers
Visit website
Investor relations